Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2008, p. 947-953, Vol. 46, No. 3
0095-1137/08/$08.00+0 doi:10.1128/JCM.02240-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Enteric Virus Unit, Virus Reference Department, Centre for Infections, Health Protection Agency, Colindale, London, United Kingdom
Received 20 November 2007/ Returned for modification 9 January 2008/ Accepted 14 January 2008
|
|
|---|
|
|
|---|
The genomic diversity of NoVs includes three genogroups (GI, GII, and GIV), 16 genotypes, and a number of provisional genotypes which have yet to be formally agreed upon. Diversity among NoVs is maintained through the accumulation of point mutations associated with the error-prone nature of RNA replication and genetic recombination involving the exchange of sequences between two related RNA viruses. Several features of RNA viruses (antigenic variation, genotypic diversity, immune escape) have been attributed to the lack of proofreading of the RNA-dependent RNA polymerases (27). The error-prone nature of template copying by RNA polymerases during virus replication (3) can lead to conserved point mutations, either silent or resulting in amino acid substitutions, but a lack of diversity within genes encoding the RNA-dependent RNA polymerases or the domain of the shell(s) of the capsid within single common genotypes makes it difficult to track outbreaks through comparisons of sequence data derived from these genomic regions (22).
The NoV capsid is divided into the S (shell) domain which constitutes the 5' end (amino acids [aa] 1 to 225) and the P (protruding) domain (aa 226 to 530) (28). The S domain contains the more highly conserved regions of the capsid and lends itself to the design of consensus primers which can amplify a wide range of genotypes within a genogroup. The P domain can be further subdivided into two subdomains, P1 and P2. The gene encoding the P2 domain contains the greatest sequence variation and corresponds to the portion of the capsid that is most exposed. Mutations in this region may have a significant effect on virus receptor binding and the host immune response to viral infection.
It is not possible to design a single primer pair which is sufficiently reactive and capable of amplifying all genotypes within a genogroup due to the diversity within the P2 domain. Genotype-specific primers are required in order to amplify this region of NoV genomes of multiple genotypes.
This study was designed to determine the potential of nucleotide sequences, derived from the P2 domain, to identify transmission events. Identification of genotype through nucleic acid sequence analysis of the S domain followed by genotype-specific P2 domain amplification and sequence analysis was able to separate or link patients within and among outbreaks more reliably than analysis of the S domain alone.
|
|
|---|
Outbreaks. Outbreaks were defined as including two or more cases of gastroenteritis linked in place and time. A new outbreak was arbitrarily defined as occurring at least 7 days after the last case in a previous outbreak or as occurring in a different patient care unit such as a ward or hospital.
RNA extraction of fecal specimens and reverse transcription assay. Small batches of fecal specimens were prepared as described previously using the guanidinium thiocyanate-silica method (10) or in larger batches using a Roche total nucleic acid extraction kit (Roche Diagnostics Ltd., Burgess Hill, United Kingdom) according to manufacturer's instructions and a Roche MagNAPure automated extractor (7). Briefly, for the guanidinium thiocyanate-silica procedure, a 200-ul fecal extract in phosphate-buffered saline was added to 1 ml of L6 buffer (Severn Biotech, United Kingdom) and 20 µl of silica, and the silica pellet was then washed with L2 buffer (Severn Biotech, United Kingdom)-70% ethanol-acetone. RNA was eluted in 40 µl of nuclease-free water (Promega, Southampton, United Kingdom), and cDNA was prepared as described previously using PdN6 random hexamers (GE Healthcare, Bucks, United Kingdom) and Moloney murine leukemia virus RTase (Invitrogen, Paisley, United Kingdom) (6).
NoV GII consensus primers. For initial genotyping, GII strains were amplified using a single-round PCR and/or a heminested PCR to increase the amplicon concentration (7, 16). PCR mix and cycling conditions were as described previously (5).
NoV GII genotype-specific P2 domain primers. PCR primers for the amplification of a region of the gene encoding the VP1 and containing the P2 domain of NoV GII genotypes 1 to 8 (12) were designed from alignments of complete Orf2 nucleotide sequence data. The forward primers correspond to nucleotide (nt) positions 5661 to 5682 and the reverse primers to nt positions 6432 to 6451 of the GII-4 strain Lordsdale/1995/UK (GenBank X86557), generating amplicons of between 785 and 818 bp (Table 1). The gene fragment encoding the P2 domain of GII strains corresponds to nt positions 5880 to 6335 of the GII-4 strain Lordsdale/1995/UK, giving an amplicon of between 445 to 492 bp, and a region of 459 bp was used for sequence analysis. PCR cycling conditions were 94°C for 2 min followed by 40 cycles of 94°C for 30 s, 45°C for 1 min, and 72°C for 1 min followed by a final 72°C for 5 min. The annealing temperature was adjusted depending on the GII genotype (see Table 1).
|
View this table: [in a new window] |
TABLE 1. Norovirus genogroup II genotype-specific primers for amplifying a region encompassing the P2 domain
|
DNA was purified using a commercially available spin column PCR purification kit (Geneclean; QbioGene) and was sequenced in both directions using NoV GII genotype P2 domain-specific primers (see Table 1), a CEQ Dye cycle sequencing Quick Start kit according to the instructions of the manufacturer (Beckman Coulter, High Wycombe, United Kingdom), and a Beckman Coulter CEQ8000 capillary sequencer.
Generation of consensus sequences and pairwise alignments of the interprimer regions (P2 GII-genotype F/P2 GII-genotype R) of sequences was performed initially using Genebuilder and Clustal in Bionumerics version 3.5 (Applied Maths, Kortrijk, Belgium). Sequence analysis was performed using the 459-bp region of the P2 domain region.
|
|
|---|
Norovirus genogroup II genotyping validation. Fecal samples for NoV genogroup II, genotypes 1 to 8, were all successfully amplified using the genotype-specific primers designed to provide amplicons encompassing the P2 domain (Table 1). Phylogenetic analysis of the P2 domain sequences differentiated between genotypes (Fig. 1).
![]() View larger version (8K): [in a new window] |
FIG. 1. Phylogenetic analysis of the P2 domain of the GII genotypes. P2 domain sequences from study strains are available from the corresponding author. P2 domain GII-1 to GII-8 primers sets were used (see Table 1).
|
![]() View larger version (12K): [in a new window] |
FIG. 2. Diversity within and among outbreaks: NoV P2 domain nucleotide sequence similarity among outbreak samples collected between December 2006 and April 2007 from several wards in two hospitals within the same NHS trust and from hospitals in different geographical regions. P2 domain GII-4 primer sets were used (see Table 1). Strain designations, outbreak numbers, and clusters are shown.
|
![]() View larger version (10K): [in a new window] |
FIG. 3. GII-4 NoV outbreaks reported between December 2006 and March 2007 in two neighboring hospitals within the same NHS trust. Three clusters are shown as well as the ward designations and outbreak numbers related to strains shown in Fig. 2.
|
![]() View larger version (10K): [in a new window] |
FIG. 4. Similarity among NoV outbreaks reported between December 2006 and September 2007 from different regions of England and Wales. NE, northeast; NW, northwest; SW, southwest. P2 domain GII-4 primer sets were used (see Table 1).
|
![]() View larger version (23K): [in a new window] |
FIG. 5. Dendrogram of P2 domain nucleotide sequences and similarity matrix of two NoV outbreaks on the same cruise ship sailing in the Pacific Ocean. The outbreaks in 2007 were S in March (a) and S1 in June (b). P2 domain GII-4 and GII-5 primer sets were used (see Table 1).
|
|
|
|---|
The ubiquitous nature of noroviruses and their association with symptomatic and asymptomatic infection (1) and the global distribution of a predominant strain, GII-4, make it difficult to follow transmission events. Some success in plotting transmission events has been reported, but this has been associated with either an uncommon strain (25) or a newly emerged variant of a common strain (2) in which there is little genetic variation other than the variants defining the mutations. Attempts to align molecular epidemiology with classical epidemiology have shown limited success, as the nucleotide regions chosen for analysis were unable to truly discriminate between outbreaks (22). Dingle (2) demonstrated that analysis of 3,255 nt of the 3' terminus of NoV strains was able to generate clusters of related stains and postulated that this method could be used to discriminate between outbreaks and transmissions among wards and identify simultaneous infections of a large number of patients and environmental contamination.
In this study, the hypervariable region of the genome encoding P2 was chosen for analysis, as this was the least conserved, whereas whole-capsid sequencing is likely to dilute differences among strains through the inclusion of conserved sequences. Also, the practicality of sequencing up to 827 bp compared with 3,255 bp allows this method to be used for the routine surveillance of transmission events. Strains with identities of 100% were regarded as having been derived from a common source, whereas strains with one or more mutations in the region sequenced were regarded as representing unrelated transmission events. Only one sample was obtained from each patient, and the short duration of NoV illness would make it unlikely that more than one sample would be submitted.
This method allowed the identification of outbreaks linked within a hospital but involving different wards and between hospitals within the same NHS Trust, where patients were likely to be transferred between NHS care units. Also, it allowed outbreaks to be better defined in terms of duration and location. Previously, outbreak definitions have suggested that a new outbreak has occurred when there is a break of 7 days between the last case in the first outbreak and the first case of the second outbreak, but this takes no account of asymptomatic spread among immune staff members or patients. With no clear history of the movement of ill patients or staff members between wards or hospitals, outbreaks are usually defined as occurring within a ward or care unit. Based on this study, analysis would suggest that in hospital 1, only two outbreaks occurred, one in December 2006, lasting for 16 days and involving three wards, that was initially thought to represent four separate outbreaks, and a second, of longer duration, initially recorded as five outbreaks in four wards, lasting from 18 January to 6 March 2007. The long duration of this outbreak may have been linked to the constant introduction of susceptible individuals into this environment. Hospital 2 suffered two outbreaks in January 2007, the first initially recorded as five separate outbreaks in five wards and lasting 7 days and the second outbreak as caused by a GII-4 strain associated with an outbreak occurring at the same time in a sister hospital within the same NHS Trust. Although two outbreaks occurred simultaneously in hospital 2, sequence analysis allowed discrimination between the GII-4 strains causing these outbreaks and clearly identified two separate introductions.
GII-4 strains from outbreaks occurring at the same time but in different geographical regions of England were clearly different from those isolated in the London hospitals, and although the majority of the strains were different from each other, two strains from two different hospitals located in the same geographical region were identical. This may suggest movement of infected individuals or staff members between the two hospitals. The analysis of nucleotide similarity among representative strains of all outbreaks confirmed that among unrelated outbreaks, similarity was less than 100%.
Noroviruses can be introduced onto cruise ships by symptomatic or asymptomatic embarking passengers, by infected crew members, by contaminated food stuffs, or, during the cruise, by passengers returning from daily excursions. The numerous sources of infectious virus often result in outbreaks associated with more than one introduction and possibly occurring by more than one route. Different interventions may be used to prevent the introduction of NoVs by these routes, but such interventions can only be successful when the routes are accurately identified. Again, as with the hospital outbreaks, the defining of an outbreak may suggest a point source or person-to-person transmission of an outbreak strain but cannot account for multiple introductions of closely related strains.
Two NoV outbreaks occurred on the same cruise ship but at different times and during different cruises. As both were associated with different NoV genotypes, they were easily identified as separate introductions. However, analysis of the P2 regions of strains from the outbreak that occurred during the first cruise in which a GII-4 outbreak was identified revealed the introduction of seven different strains of GII-4. This may not be an unusual event, as GII-4 was the predominant global strain at the time. Gathering passengers from many locations will allow the introduction of many virus variants (23), some excreted from asymptomatically infected individuals (1). Alternatively, foodstuffs, contaminated with feces or raw sewage, are often associated with outbreaks involving multiple strains of a pathogen, but multiple pathogens are also often found in this context (5, 8). Only GII-4 NoV strains were associated with this outbreak.
The second outbreak on the cruise ship was associated with a GII-5 strain, and sequences of the gene encoding the P2 domain were analyzed using nine samples collected during this outbreak. All samples showed 100% identity at the nucleotide level, indicating a point source outbreak followed by person-to-person spread.
The analysis of genes encoding the P2 domain provides a powerful tool for the tracking of outbreaks. Interventions are often hampered by an inability to understand transmission events, which may be complicated by multiple introductions of closely related viruses into semiclosed communities. This method will provide insights into food- and water-borne transmission as well as transmission through contact with contaminated environmental surfaces.
Published ahead of print on 23 January 2008. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»